Making Drug Delivery More Effective

The Life Sciences industry is poised to undergo a rapid transformation as regulatory agencies are aggressively opening the door wider to the use of computer modeling and simulation results as evidence in submissions.

In this webinar, we explore the arguments for simulation in Life Sciences and the future of population-based research and product development.  We then provide an overview on how computer modeling and simulation provides significant value to the Pharma/Biotech segment, in which both manufacturing processes and medical devices are of critical importance for companies looking to accelerate innovation, including:

• Manufacturing processes such as powder compaction, particle mixing, and clean room air flows.
• Packaging simulations to optimize product integrity under environmental and handling conditions
• Combination products and drug delivery devices and processes, which are becoming increasingly important for therapeutic efficacy and patient satisfaction.
• Novel and emerging technologies such as virtual human modeling, multiscale modeling, machine learning, and uncertainty quantification, which are beginning to transform the overall patient experience and are expected to grow in the future.